Article Listing - NICE "green light" for Novartis' Tobi Podhaler and Forest's Colobreathe

SP-PG FOR KAPOSI'S SARCOMA?

23 March 1992

A new experimental compound which could prove useful as a treatment for AIDS patients with Kaposi's sarcoma has been described...

US APPRO OF J&J's HEP C TEST

23 March 1992

The US Food and Drug Administr-ation has licensed Johnson and Johnson's new sensitive blood screening test for the hepatitis C...

UK MARKETING OF MAXEPA

23 March 1992

The only prescription formulation of the fish oil-derived omega-3 fatty acid product Maxepa is to be marketed in the UK...

EC COMMISION/PARLIAMENT MOVES

23 March 1992

The European Parliament agreed at its plenary session last week to defer yet again a vote on the much-delayed Rothley...

HYPOLIPIDEMICS INFO

23 March 1992

The Belgian Ministry of Health has issued a transparency sheet on hypolipidemics - the third in its series of comparative...

HOW EC PATENT EXTENSION IS SHAPING UP

23 March 1992

Last week, the Council of the Commission of the European Communities passed to the Europ-ean Parliament its common position on...

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

The task of pharmaceutical industry management is to achieve the best possible balance between the constant pull of the...

GENZYME CYSTIC FIBROSIS BUY-BACK

23 March 1992

Genzyme Corp and Neozyme say that, subject to completion of a proposed public financing of newly-formed Neozyme II Corp, Gen-zyme...

FRANCE PROBES GLAXO'S IMIGRAN PROMOTION

23 March 1992

The French government has commissioned a report on the pharmaceutical industry's promotional methods, following what it considers to be excessively...

CHILE COMPLETES ITS PATENT LAWS REFORMS

23 March 1992

One of the many features which differentiate the Chilean pharmaceutical sector from that of other Latin American countries is that...

Showing 94541-94550 of 95333 articles